Weston Medical see Intraject flotation:
This article was originally published in Clinica
Weston Medical, a Cambridge, UK-based company, which has developed the Intraject needle-free liquid injector device, is seeking to raise £50 million ($80 million) on the London Stock Exchange. The company has six licence collaborations with drugs companies for use of its injectors. However, at a recent drug delivery conference, the company's CEO Cristopher Samler predicted that companies such as his only had a 10-year window of opportunity before more sophisticated oral drug formulations reduced the need for needle-free drug delivery (see Clinica No 898, p 15).
You may also be interested in...
Announcing his “first step to take on pricing of generic drugs,” billionaire Mark Cuban recently associated his name with a new US generics company “to show that capitalism can be compassionate.” In an exclusive chat with Generics Bulletin, the newly established company’s CEO Alex Oshmyansky revealed that they started working on the company “in stealth” since 2018.
GSK is transferring technology to make its malaria vaccine antigen to Bharat Biotech and by 2029 will also transfer rights to supply the vaccine to WHO-approved immunization programs. The deal is expected to improve access via lower cost of the vaccine for such programs
Rules covering OTC medical devices, herbals and online activities have been added for the first time to the Irish Pharmaceutical Healthcare Association's Self-Care Advertising Code.